PAIN MANAGEMENT DEVICES MARKET ANALYSIS

Pain Management Devices Market, by Type (Neuromodulation & Neurostimulation Devices, Analgesic Infusion Pumps, and Ablation Devices), By Application (Neuropathic Pain, Cancer Pain, Facial & Migraine Pain, Musculoskeletal Pain, and Others), by End User (Hospitals, Clinics, and Others) and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) -

Published In : Jul 2023
Code : CMI3947
Pages :150
Formats :
Excel and PDF
Industry : Medical Devices

Market News

Global Pain Management Devices Market: Key Developments

In March 2022, BioElectronics Corporation, announced that its distribution partner in Mexico has received authorization from Mexican FDA (Cofepris), which allows for the importation of the RecoveryRx device into Mexico. Novro Med S.A. de C.V. has contracted for the exclusive distribution rights for RecoveryRx in Mexico.

In December 2022, Abbott, announced the U.S. Food and Drug Administration (FDA) approval of the company's Eterna spinal cord stimulation (SCS) system– the smallest implantable, rechargeable spinal cord stimulator currently available on the market for the treatment of chronic pain. Eterna SCS utilizes Abbott's proprietary low-dose BurstDR stimulation, the only SCS waveform technology with the highest level of clinical evidence (1A evidence), proven to reduce pain 23% more than traditional waveform technology approaches.